AWG
LVTX

Alpha Wave Global’s LAVA Therapeutics LVTX Stock Holding History

Alpha Wave Global’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-87,397
Closed -$145K – 24
2024
Q3 		$145K Hold
87,397
– – 0.04% 19
2024
Q2 		$157K Sell
87,397
-20,509
-19% -$54.1K 0.05% 21
2024
Q1 		$359K Hold
107,906
– – 0.11% 19
2023
Q4 		$170K Sell
107,906
-1,191
-1% -$1.7K 0.08% 18
2023
Q3 		$163K Hold
109,097
– – 0.1% 18
2023
Q2 		$221K Sell
109,097
-10,419
-9% -$19.2K 0.15% 20
2023
Q1 		$198K Hold
119,516
– – 0.07% 36
2022
Q4 		$418K Sell
119,516
-1,677
-1% -$7.7K 0.08% 59
2022
Q3 		$554K Hold
121,193
– – 0.07% 86
2022
Q2 		$347K Hold
121,193
– – 0.04% 102
2022
Q1 		$533K Hold
121,193
– – 0.05% 96
2021
Q4 		$667K Sell
121,193
-19,036
-14% -$125K 0.07% 82
2021
Q3 		$830K Sell
140,229
-4,673
-3% -$33.6K 0.06% 102
2021
Q2 		$1.58M Sell
144,902
-5,552
-4% -$68.8K 0.1% 78
2021
Q1 		$2.29M Buy
+150,454
New +$2.07M 0.14% 67

Other funds holding LVTX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PFA
Pathway Financial Advisors South Burlington, Vermont $857M AUM 17.21% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Alpha Wave Global's LVTX Position: Q4 2024 in Review

Alpha Wave Global sold out of LAVA Therapeutics (LVTX) in Q4 2024, closing a stake of 87,397 shares — an estimated $145K sold.

Alpha Wave Global first reported a position in LVTX in Q1 2021 and held it in 15 quarters. The position peaked at $2.29M in Q1 2021. 22 funds tracked by Wall St. Rank hold LVTX as of Q4 2024.

  • Alpha Wave Global reported no remaining LAVA Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Alpha Wave Global sold 87,397 LAVA Therapeutics shares in Q4 2024, an estimated $145K.
  • Alpha Wave Global first reported a position in LAVA Therapeutics in Q1 2021 and held it in 15 quarters.
  • Alpha Wave Global's LAVA Therapeutics position peaked at $2.29M in Q1 2021.
  • 22 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2024.

Based on Alpha Wave Global's 13F filing for Q4 2024, filed 13 Feb 2025.